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Transient cardiomyocyte fusion regulates cardiac
development in zebrafish
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Cells can sacrifice their individuality by fusing, but the prevalence and significance of this
process are poorly understood. To approach these questions, here we generate transgenic
reporter lines in zebrafish to label and specifically ablate fused cells. In addition to skeletal
muscle cells, the reporters label cardiomyocytes starting at an early developmental stage.
Genetic mosaics generated by cell transplantation show cardiomyocytes expressing both
donor- and host-derived transgenes, confirming the occurrence of fusion in larval hearts.
These fusion events are transient and do not generate multinucleated cardiomyocytes.
Functionally, cardiomyocyte fusion correlates with their mitotic activity during development
as well as during regeneration in adult animals. By analyzing the cell fusion-compromised
jam3b mutants, we propose a role for membrane fusion in cardiomyocyte proliferation and
cardiac function. Together, our findings uncover the previously unrecognized process of
transient cardiomyocyte fusion and identify its potential role in cardiac development and
function.
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Cell fusion is an indispensable process in diverse physiolo-gical and pathological events. Fusion of myoblasts intomultinucleated syncytia is fundamental to skeletal myo-
genesis in most organisms1. Myeloid lineage cells also undergo
homotypic fusion to generate bone-resorbing osteoclasts and
chronic inflammatory giant cells2. Cancer cell fusion with bone
marrow-derived cells has been proposed to serve as a mechanism
of metastasis and generation of cancer stem cells3. Moreover, the
concept of fusion-mediated reprogramming of differentiated cells
is well established4–6. Although cell fusion is involved in a wide
range of cellular processes and holds therapeutic promise, our
understanding of the underlying mechanisms and significance of
cell fusion remains limited, mainly due to the lack of experi-
mental models that allow in vivo visualization of fusion events.
Fusion-mediated cell fate reprogramming, observed in stem-
somatic cell heterokaryons, could aid tissue regeneration through
its potential to revert the somatic cell differentiated state and
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therapeutic potential of cell fusion relates to the reversal of altered
phenotypes through fusion-mediated complementation of reces-
sive mutations using wild-type cells, as shown in the liver7, 8.
Mammalian cardiomyocytes have long been considered termin-
ally differentiated in association with cell cycle arrest during the
maturation of the myocardium9. The ability to stimulate mature
cardiomyocyte de-differentiation and cell cycle re-entry, as likely
occurring in the adult zebrafish heart after injury10, 11, has been a
primary goal in regenerative medicine. While fusion between
cardiomyocytes and bone marrow-derived progenitor cells con-
tributes minimally to the generation of new cardiomyocytes in the
injured mouse heart12, the role of cell fusion in cardiac regen-
eration is yet to be explored.
In vivo assessment of cell fusion has thus far primarily relied
on transplanting specific cell types, genetically marked, into
unmarked or differentially marked host animals13–15. While
providing essential information about the fusion competency of
the cell types under study, these transplantation methods cannot
identify unknown fusion events. Sporadic fusion between cardi-
omyocytes and circulating cells, while rarely occurs, have been
consistently reported in healthy13 and infarcted14, 15 myocardium
following bone marrow transplantation of sublethally irradiated
mice. The earlier observation of somatic-to-embryonic stem cell
reprogramming upon fusion5 leads to the hypothesis that fusion
with blood progenitors might be able to drive post-mitotic car-
diomyocytes to proliferation15, 16. However, the low frequency of
these fusion events has hindered the assessment of their potential
benefit14, 16. To facilitate ubiquitous detection of cell fusion
in vivo, we developed transgenic tools that utilize differential Cre
recombination to generate mosaic cell populations expressing
either a GAL4 driver or a UAS based reporter. We show that
these tools successfully label fusion-derived cells. Using these
tools and genetic mosaics generated by transplantation, we
uncover a previously unrecognized fusion process that allows
transient cytoplasmic connections between cardiomyocytes in
zebrafish. Analysis of the fusion-derived cardiomyocyte popula-
tion employing our newly developed transgenic system reveals
that the occurrence of fusion correlates with their mitotic activity
during larval growth as well as after injury in adults. Corre-
spondingly, analysis of a cell fusion-deficient mutant shows that
membrane fusion positively modulates cardiomyocyte prolifera-
tion and cardiac contractility. In summary, we report here fre-
quent cardiomyocyte fusion events that occur during
development and regeneration of the zebrafish heart, as well as
their unappreciated role in myocardial growth and function.
Results
Generation of the FATC transgenic line. The best known
cell–cell fusion events are the complete merging of cell
membranes to generate multinucleated or polyploid cells1, 17,.
Additionally, fusion of cell membranes can occur in only parts
of the cell boundaries and lead to transient cytoplasmic
exchange18, 19. To distinguish between these events, we refer to
partial or transient fusion as “membrane fusion”, and complete
fusion as “cell fusion”. To identify unknown fusion events, we
generated a transgenic line, Tg(ubb:lox2272-mCerulean-UAS-
loxP-lox2272-GAL4-loxP-LIFEACT-GFP)bns97, that can report
both types of fusion (Fig. 1a). Because of the mutual incompat-
ibility of loxP and lox2272 sites20, 21, only one recombination
event will take place per transgene. Therefore, Cre recombination
stochastically leads to ubb:lox2272-GAL4-loxP-LIFEACT-GFP or
ubb:lox2272-mCerulean-UAS-loxP-LIFEACT-GFP. When these
two transgenes come together, e.g., after membrane or cell fusion,
GAL4 will bind the UAS sequence and activate LIFEACT-GFP
expression (Fig. 1b). We thus named this transgenic system
“Fluorescence Activation after Transgene Coupling” (FATC).
Suitability of a FATC line to label exclusively cells that have
undergone fusion depends on the transgene copy number, i.e., a
FATC line containing multiple transgene insertions is
expected to exhibit widespread LIFEACT-GFP expression
following Cre recombination (Fig. 1c). Thus, we first assessed
the number of transgene insertions in the Tg(ubb:FATC)bns97 line.
Tg(ubb:FATC)bns97 outcrosses generated 50% of offspring that
carried the FATC transgene, as assessed by mCerulean
expression, suggesting a single transgene insertion. Moreover,
heat-induced ubiquitous expression of cre in Tg(ubb:FATC)bns97;
Tg(hsp:cre) embryos at 24 hours post fertilization (hpf)
resulted in transgene-coupling activation of LIFEACT-GFP
expression in only a few tissues (Supplementary Fig. 1). To test
the ability of the bns97 FATC line to label fusion-derived
cells specifically, we examined LIFEACT-GFP expression in
distinct populations of skeletal myocytes. During vertebrate
myogenesis, fast twitch muscles undergo extensive fusion to
become multinucleated syncytia, whereas slow twitch muscles
remain mononucleated22. Following heat-activation of Cre
expression at 24 hpf, 5 days post fertilization (dpf) Tg(ubb:FATC)
bns97;Tg(hsp:cre) larvae showed restricted LIFEACT-GFP
expression in the cell fusion-derived multinucleated fast twitch
muscles, but not in the fusion-incompetent slow twitch muscles
(Fig. 1d, e), which are located more superficially. Besides
the skeletal tissue, LIFEACT-GFP+ cells were observed in the
skin, a tissue commonly reported to become polyploid23, 24
(Supplementary Fig. 1A). In agreement with the restricted
pattern of LIFEACT-GFP expression in these animals, we
found that three linked ubb:FATC insertions were resolved in
to a single copy following Cre recombination, suggesting
tandem insertion of the transgene in the Tg(ubb:FATC)bns97 line
(Supplementary Fig. 2).
Fig. 1 Establishment of the FATC transgenic line for in vivo labeling of fusion-derived cells. a Schematic illustration of the ubb:FATC construct and Cre
recombination products. b, c Schematic illustrations of membrane fusion (b) and multiple transgene insertions (c) that could give rise to LIFEACT-GFP
expression. b Cre recombination of Tg(ubb:FATC) animals harboring a single copy of the transgene generates two different cell populations, one carrying a
GAL4 expression cassette and the other carrying a UAS:LIFEACT-GFP (LAGFP) cassette. Fusion between cells carrying different cassettes (green arrows),
but not between cells carrying the same cassette (black arrows), leads to activation of LIFEACT-GFP expression (green). c Stochastic Cre recombination in
cells harboring two copies of the FATC transgene will generate 50% of the time cells carrying both the GAL4 and UAS:LIFEACT-GFP cassettes (green). d, e
LIFEACT-GFP expression is activated in fast twitch, but excluded from slow twitch, muscles. d Drawing of a zebrafish larva depicting the trunk area (red
box), shown in e. e Tg(ubb:FATC);Tg(hsp:cre) embryos were heat-shocked at 24 hpf, and LIFEACT-GFP expression (green) was assessed at 5 dpf. Muscle
fibers were visualized by immunostaining with EB165 and F59 (red) to label fast and slow twitch muscles, respectively. DAPI (blue) labeling shows fusion-
derived multinucleation of fast twitch muscles. f heat induction of cre expression at 24 hpf activates LIFEACT-GFP (green) expression in skeletal and
cardiac myocytes in 5 dpf Tg(ubb:FATC);Tg(hsp:cre) larvae, but not in Tg(ubb:FATC) animals (blue). g LIFEACT-GFP expression (green) labels sarcomeric
structures of FATC-activated cardiomyocytes (identifiable by membrane expression of mKATE-CAAX (red)). Absence of LIFEACT-GFP expression without
4-OHT treatment confirms the dependency of the FATC reporter on Cre activity. e, f show maximum intensity projections of 10–50 μm thick confocal
stacks. g 3D volume renderings of 90 μm thick confocal stacks of the entire cardiac ventricle. Representative images from a total of 8–9 (e), 32 (f), and 9
(g) animals are shown. Scale bars: 20 μm (e, f trunk, g), 50 μm (f heart)
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FATC labels cardiomyocytes in the developing hearts. In
addition to LIFEACT-GFP+ cells in skeletal muscle (Fig. 1e, f)
and skin, we unexpectedly observed a substantial number of
LIFEACT-GFP+ cells in the heart (Fig. 1f) after ubiquitous Cre
expression. By virtue of their location within the developing
myocardium, we posited that these cells were cardiomyocytes. To
verify the identity of these cells, we assessed FATC reporter
expression in Tg(ubb:FATC);Tg(myl7:creER);Tg(myl7:mKATE-
CAAX) larvae (Fig. 1g). myl7:creER enables cardiomyocyte-
specific expression of creER, which was activated by a 16 h
treatment of 4-OHT starting at 24 hpf. Recombination efficiency
of the same 4-OHT treatment paradigm was tested in Tg(loxP-
DsRed-loxP-EGFP);Tg(myl7:creER) embryos. Recombination-
derived EGFP+ cardiomyocytes populated ~74% of the total
cardiac ventricle area (Supplementary Fig. 3A, B). Expression of
EGFP was restricted to the heart, confirming the specific
expression of creER in the myocardium (Supplementary Fig. 3D).
Without 4-OHT treatment, Tg(ubb:FATC);Tg(myl7:creER);Tg
(myl7:mKATE-CAAX) larvae exhibited no LIFEACT-GFP
expression (Fig. 1g), indicating no leakiness of the Cre/lox sys-
tem with these transgenic lines. Following CreER activation in the
myocardium, a substantial number of LIFEACT-GFP+ cardio-
myocytes, comparable to that observed upon heat induction to
achieve ubiquitous cre expression (Fig. 1f), were detectable at 5
dpf (Fig. 1g). Membrane-localized mKATE-CAAX marked all
cardiomyocytes. Importantly, LIFEACT-GFP binding to F-actin25
showed the presence of myofibrillar arrays in all FATC-activated
cells, further confirming their cardiomyocyte identity (Fig. 1g).
Cardiomyocyte mitosis does not activate FATC. Mammalian
cardiomyocytes can become polyploid due to abortive cytokin-
esis26, 27. Besides membrane or cell fusion, Cre activity during the
polyploid state following DNA replication and preceding
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Fig. 2 Cardiomyocyte proliferation does not mediate FATC reporter expression. a Schematic illustration of the ubb:NATC construct and Cre recombination
products. b Schematic illustration of the cellular events that could occur in the experiment shown in c. c NTR-mCherry+ (red) cardiomyocytes (H2B-GFP+,
green) were observed in Tg(ubb:NATC);Tg(myl7:creER);Tg(myl7:H2B-GFP) larvae following MTZ-mediated cell ablation, 7 days after transient CreER
activation by 4-OHT treatment at 24 hpf. All images show the same heart. d NTR-mCherry expression does not succeed cardiomyocyte DNA synthesis.
The 6 h EdU pulse-labeled cells undergoing DNA synthesis (green) in 54 hpf Tg(ubb:NATC);Tg(myl7:creER) embryos. Two hours prior to EdU removal, Cre
activity was induced by an 18 h 4-OHT treatment. mCerulean (blue) and NTR-mCherry (red) expression was visualized by immunostaining. No EdU+NTR-
mCherry+ cardiomyocytes were detectable in 20 hearts imaged. c, d Maximum intensity projections of 40–60 μm thick confocal stacks. Representative
images from a total of 12 (c) and 20 (d) animals are shown. Scale bars: 10 μm (c), 20 μm (d)
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cytokinesis, might be able to induce LIFEACT-GFP expression. To
test whether mitosis-derived polyploidy accounts for the presence
of LIFEACT-GFP+ cardiomyocytes, we generated a Nitror-
eductase Activation after Transgene Coupling (NATC) construct
(Fig. 2a) by replacing the LIFEACT-GFP cassette in the ubb:FATC
construct with a cassette encoding mCherry fused to nitror-
eductase (NTR). NTR converts the innocuous drug metronidazole
(MTZ) into a cytotoxic molecule, killing the cells expressing the
enzyme28, 29. We generated the NATC line Tg(ubb:NATC)bns98,
which harbors a single insertion of the transgene (Supplementary
Fig. 2B, C). NATC reporter expression following ubiquitous cre
expression generated NTR-mCherry+ cells in specific tissues
phenocopying the behavior of the Tg(ubb:FATC)bns97 line
(Supplementary Fig. 4), suggesting that both lines are suitable
reporters of membrane or cell fusion.
Analysis of NTR-mCherry expression enabled the distinction
between NATC-activated cells derived from membrane/cell
fusion events (Fig. 2b, hypothesis 1) and those derived from
abortive cytokinesis (Fig. 2b, hypothesis 2). More specifically,
myl7:CreER activation from at 24 to 38 hpf was used to mark
cardiomyocytes generated by both processes, fusion and mitosis.
These cardiomyocytes were subsequently ablated by MTZ
treatment from 4 to 6 dpf. Thus, NATC activation at a later
time point, when CreER was most likely no longer active
(Supplementary Fig. 5) could only occur through membrane or
cell fusion. Indeed, in the same hearts in which cardiomyocytes
turning on NTR-mCherry expression before 6 dpf were ablated,
we observed re-appearance of NTR-mCherry+ cells at 9 dpf
(Fig. 2c), suggesting that membrane or cell fusion activates NATC
in the larval heart. In addition, in order to detect mitosis-derived
NTR-mCherry+ cells, we labeled newly synthesized DNA in 54
hpf Tg(ubb:NATC)bns98;Tg(myl7:creER) embryos with a 6 h pulse
of 5-ethynyl-2’-deoxyuridine (EdU) prior to CreER activation by
4-OHT treatment from 58 to 76 hpf, thereby allowing a 2 h
interval during which cardiomyocytes were exposed to both 4-
OHT and EdU (Fig. 2d). If fusion had occurred during cell
cycling, EdU+NTR-mCherry+ cardiomyocytes should be present.
However, all detectable NTR-mCherry+ cardiomyocytes in 76 hpf
larvae lacked EdU incorporation, indicating that NATC activa-
tion does not occur during cell division (Fig. 2d). Together, these
findings suggest that the expression of NTR-mCherry in the
myocardium is not due to Cre activity during cell cycling or due
to cytokinesis delay/failure, but reports cardiomyocyte fusion.
Homotypic cardiomyocyte membrane fusion. Thus far, only the
ability of cardiomyocytes to undergo heterotypic fusion with
other cell types has been reported13–15. Homotypic or heterotypic
fusion could give rise to F/NATC activation following ubiquitous
cre expression (Fig. 1f). By contrast, cardiomyocyte-specific myl7:
creER expression should label mainly homotypic fusion-derived
cells (Figs. 1g and 2c). However, remaining CreER activity after
heterotypic fusion of cardiomyocytes with other cells might be
able to activate F/NATC. To directly visualize the occurrence of
cardiomyocyte fusion events in the developing heart, we per-
formed time-lapse imaging of 54 hpf embryos in which cardio-
myocytes were labeled by membrane mKATE-CAAX and nuclear
H2B-GFP expression. Heartbeat in these embryos was blocked by
morpholino-mediated knockdown of the tnnt2 gene30, which
encodes cardiac muscle troponin T. Interestingly, 16 h long live
imaging captured several events of localized cell membrane fusion
between neighboring cardiomyocytes, which allowed cytoplasmic
connections between them. These events were only transient as
new membranes were established shortly afterwards (Fig. 3;
Supplementary Movie 1). The observed dissolving and/or re-
establishment of plasma membranes might occur during different
cellular processes including membrane rupture, completion of
cytokinesis, and membrane fusion. Membrane rupture is unlikely
to occur since it would lead to the direct connection of intra- and
extra-cellular environments resulting in drastic intracellular
changes and most likely cell death. Completion of cytokinesis in
cycling cardiomyocytes might be able to explain some of the
   
   















   



















Fig. 3 Membrane fusion occurs in the developing heart. Live imaging of Tg(myl7:MKATE-CAAX);Tg(myl7:H2B-GFP) embryos, in which heartbeats were
blocked by morpholino-mediated tnnt2 knock-down (Supplementary Movie 1), showing establishment of a new membrane border (arrows) between
cardiomyocytes 1 and 2, which initially exhibited cytoplasmic continuum. The plasma membrane border between cardiomyocytes 1 and 3 (arrowheads)
dissolved and was subsequently re-established. mKATE-CAAX (red) and H2B-GFP (green) expression labeled cardiomyocyte membranes and nuclei,
respectively. Timing of each still image is hour:minute. All images are 3D volume renderings of 60 μm thick confocal stacks of a representative heart
showing the myocardial monolayer observed from the lumen. Examples of cytoplasmic continuum between cardiomyocytes were observed in all 6 hearts
examined. Scale bar: 20 μm
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myl7:EGFP; myl7:nDsred2; 3 dpf
myl7:EGFP; myl7:nDsred2; 3 dpf myl7:EGFP; myl7:nDsred2; 3 dpf
Fig. 4 Blastula transplantations reveal cardiomyocytes expressing both donor and host transgenes. a Schematic drawing of transplantation experiment
shown in b–d. Tg(myl7:EGFP) cells were transplanted into Tg(myl7:nDsred2) hosts at the blastula stage. b–d Cardiomyocytes expressing both host-derived
myl7:EGFP (green cytoplasm) and donor-derived myl7:nDsred2 (red nucleus) transgenes (b) are evident from orthogonal sections (c) and Y axis rotation of
a 3D volume rendering (d). EGFP+nDsred2+ cardiomyocytes (white circle) were detected in 9 out of 18 mosaic hearts at 3 dpf. e Schematic drawing of
transplantation experiment shown in f–h. Tg(actb2:loxP-mCherry-loxP-EGFP) cells were transplanted into Tg(myl7:creER) hosts at the blastula stage.
Transplanted animals were treated with 4-OHT starting at 24 hpf. New 4-OHT was added to the embryo medium daily. f A single focal plane of a confocal
stack shows a dorsal view of a 3 dpf chimeric heart, anterior up. Donor-derived mCherry+ cells (red) and fusion-derived EGFP+ cardiomyocytes (green,
arrows) were detected by live imaging in 5 out of 13 mosaic hearts (mixed genotypes, creER+ and creER−). g Maximum intensity projection of a 50 μm
confocal stack shows a lateral view of a 7 dpf chimeric heart, anterior up, dorsal to the left. Tg(actb2:loxP-mCherry-loxP-EGFP) donor cells are shown in red.
Host-derived Cre-mediated recombination of the donor transgene was detectable by EGFP immunofluorescence (green) in 11 out of 39 mosaic hearts
(mixed genotypes, creER+, and creER−). h Magnified image showing area outlined by red box in g. Scale bars: 20 μm
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observed events (for example see arrow between cardiomyocytes
1 and 2 in Fig. 3). However, the dissolving and re-establishment
of cell membranes at the interface of other adjacent cardiomyo-
cytes (for example see arrowhead between cardiomyocytes 1 and
3 in Fig. 3) are most likely caused by transient membrane fusion
events. Consistent with this interpretation, our previous obser-
vations of the NATC reporter (Fig. 2c) indicate that
cardiomyocyte fusion does not occur during mitosis. Thus, our
findings provide evidence for the occurrence of transient mem-
brane fusion between cardiomyocytes.
Cardiomyocyte fusion is detectable by cell transplantation. To
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cardiomyocytes, we used a transplantation approach to create
mosaic animals. Cells from Tg(myl7:EGFP) blastulae were trans-
planted into Tg(myl7:nDsRed2) blastulae (Fig. 4a). In 9 out of 18
mosaic hearts, we observed cardiomyocytes expressing both
donor- and host-derived transgenes at 3 dpf (Fig. 4b–d). Ortho-
gonal sections (Fig. 4c) and 3D surface renderings (Fig. 4d)
confirmed the presence of cytoplasmic EGFP and nuclear DsRed2
in these cardiomyocytes. We also used Tg(actb2:loxP-DsRed-loxP-
EGFP) embryos as donors and Tg(myl7:creER) embryos as hosts
(Fig. 4e). In this case, fusion would lead to EGFP expression after
CreER-mediated recombination in cardiomyocytes. Following
daily 4-OHT treatment starting at 24 hpf, EGFP+ cells were
detectable in 5 out of 13 mosaic hearts at 3 dpf (Fig. 4f).
These EGFP+ cells were localized in the single-layered compact
wall or in the trabeculae, suggesting their cardiomyocyte
identity. At later developmental stages, between 5 and 7 dpf, we
were also able to detect EGFP+ cardiomyocytes in 11 out of 39
mosaic hearts (Fig. 4g, h). Together with our observations on
Tg(ubb:FATC)bns97 and Tg(ubb:NATC)bns98 animals, data from
these two transplantation-based strategies provide strong
evidence for fusion events that lead to the formation of cytosolic
connections and allow the exchange of mRNAs and/or proteins
between cardiomyocytes.
F/NATC labels a proliferative pool of cardiomyocytes. To better
characterize fusion-derived cells and understand the functional
implications of membrane fusion, we first determined the numbers
of cardiomyocytes turning on F/NATC. Following induction of
cardiomyocyte-specific CreER activity by 4-OHT treatment from
24 to 40 hpf, expression of LIFEACT-GFP was assessed in 3 dpf, 5
dpf, and 6 months post fertilization (mpf) Tg(ubb:FATC)bns97;
Tg(myl7:creER);Tg(myl7:nDsRed2) fish. On average, 5.2± 0.5% of
all ventricular cardiomyocytes, identified by nDsRed2 expression,
were LIFEACT-GFP+ at 3 dpf. This proportion increased to an
average of 11.7± 1.1% at 5 dpf (Fig. 5a, c). Interestingly, the
proportion of LIFEACT-GFP+ cardiomyocytes decreased to
5.5± 1.7% in adults (Fig. 5b, c). This reduction is in line with the
transient nature of the membrane fusion events observed by time-
lapse imaging (Supplementary Movie 1; Fig. 3). As FATC reporter
expression relies on the presence of both GAL4 protein and UAS:
LIFEACT-GFP in the same cell, transient fusion that does not
generate multinucleated cells would thus lead to only short-lived
LIFEACT-GFP expression. Using the same Cre induction
regimen, we detected similar numbers of NTR-mCherry+
cardiomyocytes in Tg(ubb:NATC)bns98;Tg(myl7:creER);Tg(myl7:
H2B-GFP) fish (Fig. 5d, e).
The relatively low percentage of F/NATC-activated cardio-
myocytes in the adult myocardium, a tissue with low proliferation
rate in physiological conditions (Fig. 5b) prompted us to test for a
possible link between membrane fusion and mitotic activity.
Thus, we next sought to analyze the mitotic activity of NTR-
mCherry+ cardiomyocytes in Tg(ubb:NATC)bns98 animals. Sur-
prisingly, while NTR-mCherry+ cardiomyocytes constituted 8.3
± 0.6% and 16.6± 0.8% of the total cardiomyocytes in the 3 and
5 dpf ventricular myocardium (Fig. 5d, e), their contribution to
the proliferating pool of cardiomyocytes was markedly higher. In
3 dpf Tg(ubb:NATC);Tg(myl7:creER) larvae treated first with 4-
OHT to activate Cre at 48 hpf, and then with a 6 h pulse of EdU
to label proliferative cells, 16.6± 3.4% of all ventricular EdU+
cardiomyocytes were also NTR-mCherry+ (Fig. 5f, h). In 5 dpf Tg
(ubb:NATC);Tg(myl7:creER) larvae in which Cre was activated at
24 hpf, this proportion increased to 40.9± 3.4% (Fig. 5g, h),
corresponding to an ~2.5-fold enrichment of NTR-mCherry+
cells in the proliferating cardiomyocyte population. Together,
these findings put forth a hypothesis that the cardiomyocytes
which experienced membrane fusion represent a highly pro-
liferative subpopulation in the developing heart. Two observa-
tions support this hypothesis. First, membrane fusion precedes
proliferation. Analysis of NATC larvae treated with 4-OHT prior
to exposure to a short pulse of EdU showed that substantial
numbers of cardiomyocytes were NTR-mCherry+EdU+ double-
positive (Fig. 5f–h); however, analysis of NATC larvae treated
with an EdU pulse given prior to Cre induction detected no
NTR-mCherry+EdU+ double-positive cardiomyocytes (Fig. 2d).
Second, F/NATC+ cardiomyocytes have higher mitotic rates:
analyses of the percentages of NATC+ cardiomyocytes (Fig. 5d, e)
and the proliferating pool (Fig. 5f–h) determine the proportion of
cycling NATC+ cardiomyocytes to be approximately 2.4 and 3.4
times higher than NATC− cardiomyocytes at 3 and 5 dpf,
respectively. Indeed, we found the percentage of cycling NATC+
cardiomyocytes (calculated from EdU+NTR-mCherry+/NTR-
mCherry+) to be on average 9.9± 1.1%, in comparison to
2.5± 0.2% for the general cardiomyocyte population in 5 dpf
ventricles (Fig. 5i). Of note, we also assessed myl7:CreER-driven
recombination efficiency with the same 4-OHT treatment
regimens used to assess F/NATC activation. In Tg(act2b:loxP-
DsRed-loxP-EGFP);Tg(myl7:creER) embryos, GFP+ cardiomyo-
cytes covered ~74–75% of the total ventricular area, as measured
by the area comprised of both DsRed+ cells and GFP+ cells
(Supplementary Fig. 3A–C). However, the partly overlapping
DsRed and GFP signals resulted in higher signal intensity as
compared to GFP signal alone. Consequently, image thresholding
might have led to an underestimate of the GFP+ ventricular area,
and consequently recombination efficiency. Therefore, assuming
a minimum of 74.1± 4.8% recombination efficiency might lead to
an underestimation of the actual percentages of F/NATC+ and
NATC+EdU+ cardiomyocytes.
Cardiac regeneration induces F/NATC reporter expression.
The regenerative response of the adult zebrafish heart is
Fig. 5 F/NATC-labeled cardiomyocytes are highly proliferative. a–c FATC-activated (LIFEACT-GFP+, green) cardiomyocytes (nDsRed+, red) in 3 and 5 dpf
(a) and 6mpf (b) Tg(ubb:FATC);Tg(myl7:creER);Tg(myl7:nDsRed2) fish treated with 4-OHT from 24 to 40 hpf were quantified as percentages of total
ventricular cardiomyocytes (c). The same fish were analyzed at 3 and 5 dpf (a, c). d, e NTR-mCherry+ (red) cardiomyocytes (H2B-GFP+, green) of 3 and 5
dpf Tg(ubb:NATC);Tg(myl7:creER);Tg(myl7:H2B-GFP) fish treated with 4-OHT starting at 24 hpf (d) were quantified as percentage of total ventricular
cardiomyocytes (e). f–h NTR-mCherry+ cardiomyocytes contribute substantially to the proliferating subset of cardiomyocytes. Tg(ubb:NATC);Tg(myl7:
creER) embryos were treated with 4-OHT starting at 48 (f) or 24 (g) hpf to identify NATC-activated cardiomyocytes (mCerulean+,blue, and mCherry+,
red). A 6 h EdU pulse (green) starting at 72 (f) or 120 (g) hpf labeled cells undergoing DNA synthesis. Arrowheads point to mCerulean+mCherry+EdU+
cardiomyocytes, which were quantified as percentages of total EdU+ ventricular cardiomyocytes (h). i Percentages of proliferating cardiomyocytes,
assessed by a 6 h pulse of EdU, relative to total cardiomyocytes and relative to the NTR-mCherry+ cardiomyocyte population in 5 dpf Tg(myl7:nuDsRed2)
and Tg(myl7:creER);Tg(ubb:NATC) ventricles, respectively. Three-dimensional volume renderings (a, d) and maximum or average intensity projections (b, f,
g) of 90 (a, b), 84 (d), and 10–14 (f, g) μm thick confocal stacks are shown. In c, e, h and i, bars and error bars represent means± S.E.M. Each circle (n= 12
in c, 20 in e, 10 in h, and 9 in i), triangle (n= 12 in c, 20 in e, 19 in h, and 19 in i), and square (n= 3) represents a cardiac ventricle. **p≤ 0.01, ***p≤ 0.001
(two-tailed student’s t-test). Representative images from a total of 12 (a), 3 (b), 18 (d), 11 (f), and 19 (g) animals are shown. Scale bars: 20 μm (a, d, f, g),
50 μm (b)
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Fig. 6 Transgene coupling-mediated fluorescence expression in the adult heart increases after injury. a–c Cardiac injury induces NATC reporter expression.
6 mpf Tg(ubb:NATC);Tg(myl7:creER) fish were injected with 4-OHT intraperitoneally 30 days prior to cryoinjury. a Whole-mount immunostaining revealed
that NTR-mCherry+ cardiomyocytes (red) were localized mainly adjacent to the damaged area (dashed line), identified by disorganized cardiac cells
(DAPI+, blue). b Cytoplasmic NTR-mCherry (red) and nuclear DAPI (blue) labeling shows sham- and injury-induced NATC-activated cardiomyocyte
morphologies; arrowheads point to double-labeled cardiomyocytes. c Ratios of mean gray values of NATC and DAPI labeling were calculated from
maximum intensity projections of 200 μm thick confocal images of individual hearts. d Many NTR-mCherry+ cardiomyocytes (red) detected mainly at the
lesion border zone (disorganized cardiac cells are revealed by DAPI staining, blue) were phospho-histone H3 (pH3, green) positive. e, f The majority of
mitotic cardiomyocytes at the lesion border zone show NATC reporter expression. e NTR-mCherry (red) and myosin heavy chain (MHC, green)
expression were detected by immunostaining of 6 mpf sham-operated and cryoinjured Tg(ubb:NATC);Tg(myl7:creER) hearts, in which Cre had been
activated by 4-OHT treatment from 24 to 40 hpf. NTR-mCherry+ cardiomyocytes undergoing mitosis (white circles) were detected with an 8 h EdU pulse
(EdU+ nuclei are in white) and their numbers were quantified as percentages of total numbers of mitotic cardiomyocytes (f). Cardiac cells were visualized
by DAPI (blue) staining. Representative Tg(ubb:NATC);Tg(myl7:creER) hearts from four sham and six injured hearts (a–d), and three sham and three injured
hearts (e, f) are shown/analyzed. Images are maximum or average intensity projections (a, e) and 3D volume renderings (d, e) of 200–300 (a), 20 (b, e),
and 300 (d) μm thick confocal stacks. Bars and error bars in c, f represent mean± S.E.M. Each circle (n= 4 in c and 3 in f) and triangle (n= 6 in c and 3 in
f) represents a heart. *p≤ 0.05, **p≤ 0.01 (two-tailed student’s t-test). Scale bars: 5 μm (b), 20 μm (e), 30 μm (d), 50 μm (a)
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characterized by a burst of cardiomyocyte dedifferentiation and
proliferation10, 11, providing another model to test the correlation
between NATC reporter expression and proliferation in cardio-
myocytes. We first induced CreER activity by intraperitoneal (IP)
injection of 4-OHT in adult Tg(ubb:NATC)bns98;Tg(myl7:creER)
fish. An earlier study had shown that a single dose of 50 ng of 4-
OHT delivered by IP injection to adult Tg(myl7:creER);Tg(actb2:
loxP-DsRed-loxP-EGFP) zebrafish led to ~20% of the ventricular
cardiomyocytes to express EGFP11. We chose a 200 times higher
dose of 4-OHT for our experiments and thus expected a con-
siderably higher recombination efficiency. Thirty days following
cardiomyocyte-specific CreER activation, we performed cardiac
cryoinjuries. Seven days after cryoinjury, we detected a noticeable
increase of NTR-mCherry expression in the injured hearts
(Fig. 6a–c; Supplementary Fig. 6D–H), while sham-operated ones
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Fig. 7 Cell fusion deficiency negatively affects cardiomyocyte proliferation and cardiac function. a–d jam3b mutants show a reduction in the number of
LIFEACT-GFP+ skeletal and cardiac myocytes. Embryos from a cross of jam3b+/−;Tg(ubb:FATC) and jam3b+−;Tg(hsp:cre) fish were heat-shocked at 24 hpf.
LIFEACT-GFP+ (green) skeletal (a) and cardiac (b) muscles were detectable at 48–52 hpf. DAPI-stained nuclei are shown in blue. c, d LIFEACT-GFP+
skeletal myocytes per 10,000 μm2 of trunk surface area (c) and LIFEACT-GFP+ ventricular cardiomyocytes (d) in jam3b−/− embryos and jam3b+/? siblings.
e–g Jam3b deficiency reduces cardiomyocyte proliferation. A 16 h EdU pulse (green) labeled mitotic cardiomyocytes (nDsRed+, red) (e) shown as
percentage of total cardiomyocytes (f); total cardiomyocyte numbers (g) in ventricles of 6 dpf jam3b−/−;Tg(myl7:nDsRed2) and jam3b+/?;Tg(myl7:nDsRed2)
siblings. h–j jam3b deficiency impairs cardiac function. h The 5 dpf jam3b mutants exhibit pericardial edema (28 out of 36 fish with edema were jam3b−/−).
i, j The 5 dpf jam3b mutants also display decreased fractional shortening (i) and blood flow velocity (j) compared to control siblings, as evidenced by a
significant difference in average maximum flow velocity (k). a, b, e are maximum or average intensity projections of 20–65 μm thick confocal stacks.
h are single focal planes of confocal images showing larvae in lateral views, anterior up and dorsal to the left. In all plots, bars and error bars represent
means± S.E.M. Each circle and triangle represents an embryo (c) or a heart (d, f, g, k, j). *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001 (two-tailed student’s t-test);
10–12 (a–d), 16 (e–g), 36 (h), and 11–25 (i–k) −/− and +/? sibling animals were examined. Scale bars: 20 μm (a, b, e), 40 μm (h)
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Supplementary Fig. 6A–C). Most NTR-mCherry+ cells localized
at the interface between injured and healthy tissues, where car-
diomyocyte proliferation most prominently occurs10, 11.
Moreover, several NTR-mCherry+ cells exhibited atypical mor-
phology, having a more roundish shape compared to the elon-
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Fig. 8 Membrane fusion does not generate multinuclear or polyploid cardiomyocytes. a Mononucleated NATC-activated cardiomyocytes undergo mitosis.
Tg(ubb:NATC);Tg(myl7:creER) embryos were treated with 4-OHT from 48 to 56 hpf. At 72 hpf, the larvae were given a 6 h EdU pulse. Membrane Cerulean
(green) and cytoplasmic mCherry (red) expression were visualized by immunostaining. EdU (magenta) and DAPI (blue) staining shows a single nucleus in
the EdU +mCherry+ cardiomyocyte (arrowhead). 7.2 μm thick confocal stacks are shown as maximum intensity projections. b Binucleation is rarely
observed in embryonic cardiomyocytes. Images are 3D volume renderings of a 54 hpf heart. Cardiomyocyte membrane and nuclei were visualized by Tg
(myl7:GAL4);Tg(UAS:EGFP-CAAX) (green) and Tg(myl7:nDsRed2) (red) expression, respectively. Y axis rotation of the ventricular area (small panels on
the right), indicated by the white box shows the single-layered compact myocardium with a binuclear cardiomyocyte, outlined with white dashed lines. c
Among the EdU− populations, the distributions of DAPI intensity in NTR-mCherry+ cardiomyocytes (green bars) and NTR-mCherry− cardiac cells (black
bars) were similar, indicating that DNA content in fused cardiomyocytes is not different from that of non-fused cardiac cells. On the contrary, and as
expected, DNA content in EdU+ cells (red bars) was significantly higher than that in EdU− cells (either NTR-mCherry+ or NTR-mCherry−). Tg(ubb:NATC);Tg
(myl7:creER) embryos were treated with 4-OHT from 24 to 40 hpf. NTR-mCherry expression and proliferating cells were labeled by immunostaining at 7
dpf after a 16 h EdU pulse. DAPI intensity measurements were performed on 3D volume-renderings obtained from confocal images. n= 311 NTR-mCherry
−EdU− cells, n= 227 NTR-mCherry+EdU− cells, n= 173 EdU+ cells, from 5 larvae. ***p< 0.001, n.s., not significant, two-sample Kolmogorov–Smirnov test.
Representative images from 11 larvae (a) and 10 embryos (b) are shown as average intensity projections (a) and 3D surface renderings (b) of 12 (a) and 60
(b) μm thick confocal stacks. Scale bars: 20 μm (a, b small panels), 30 μm (b, large panel on the left)
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detected within the healthy tissue (Fig. 6b). This observation is
consistent with the round cells corresponding to dedifferentiated
cardiomyocytes, characterized by sarcomeric disassembly and cell
detachment prior to proliferation11. Injury-induced activation of
NATC, localization of NATC-activated cells around the lesion
area, and atypical morphology of these cells were also observed in
cryoinjured Tg(ubb:NATC)bns98;Tg(hsp:cre) fish (Supplementary
Fig. 7G–O). Consistent with our hypothesis of a link between F/
NATC reporter expression and mitotic activity in cardiomyo-
cytes, we observed that around the injured area, a substantial
number of proliferating cells, detected by the M-phase marker
Phospho-Histone H3 (pH3), showed NTR-mCherry (Fig. 6d) or
LIFEACT-GFP (Supplementary Fig. 7A–F) expression. These
data suggest that the correlation between cardiomyocyte mem-
brane fusion and proliferation in larval hearts is also present in
the regenerating adult myocardium.
Next, we examined the contribution of NATC-activated cells to
the proliferating subset of cardiomyocytes during heart regenera-
tion. We used 6mpf Tg(ubb:NATC);Tg(myl7:creER) fish treated
with 4-OHT to induce Cre activity from 24 to 40 hpf (Fig. 6e, f).
This 4-OHT treatment regimen is the same as the one used to
generate the data shown in Fig. 5a, d, g, and so is expected to yield
at least a 74% recombination efficiency (Supplementary Fig. 3).
Cells that underwent DNA synthesis were labeled by an 8 h pulse
of EdU at 7 days post injury. Cardiomyocytes were identified by
the presence of sarcomeric arrays revealed by immunostaining for
myosin II heavy chain (MHC). Consistent with our initial
observations with pH3, NATC-activated cardiomyocytes (NTR-
mCherry+MHC+) most prominently localized at the interface
between healthy and injured tissues, and constituted on average
71.5± 2.4% of the cycling cardiomyocytes in this area as
indicated by the ratio of EdU+NTR-mCherry+MHC+/EdU
+MHC+ (Fig. 6e, f).
Our findings of a high proliferative rate of F/NATC-activated
cardiomyocytes in larval hearts (Fig. 5d–h), of the extensive
contribution of F/NATC+ cells to the cycling cardiomyocytes in
regenerating adult hearts (Fig. 6d–f; Supplementary Fig. 7A–F),
and of the detection of NATC reporter expression in larval
cardiomyocytes prior to their proliferation (Figs. 2c and 5f–h)
collectively suggest an increase in cardiomyocyte proliferation
rate after membrane fusion during both development and tissue
repair.
jam3b mutation impairs cardiac development and function.
Our findings thus far support the hypothesis that membrane
fusion primes cardiomyocytes for proliferation. However, another
scenario in which cell cycle entry confers fusion capability to
cardiomyocytes is also plausible. To try and distinguish between
these possibilities, we examined zebrafish harboring a missense
mutation in the cell surface receptor gene junction adhesion
molecule (jam) 3b, reported to be indispensable for skeletal
muscle fusion31. Expression of jam3b in cardiomyocytes was
confirmed by in situ hybridization of 3 dpf Tg(myl7:H2B-GFP)
larvae (Supplementary Fig. 8A). The jam3b mutant is currently
one of the very few tools available to elucidate the functional
implication of cell fusion in zebrafish. Other molecules known to
affect cell fusion, many of which act within pathways modulating
actin filament assembly, regulate multiple aspects of tissue
development and function. On the other hand, homozygous
mutations in jam3b cause fast twitch muscle fusion defects,
without detectable effects on myocyte differentiation, myofila-
ment structure, or overall development31. Mammalian Jam3b
(JAM-C) has been reported to localize to tight junctions in epi-
thelial cells where it interacts with the tight junction-associated
protein ZO-132. First, to test whether tight junction formation
was affected by Jam3b deficiency, we assessed the amount of
ZO-1 localized to the plasma membrane of cardiomyocytes in
jam3b−/− larvae. As shown in Supplementary Fig. 8B, C,
jam3b−/− animals showed comparable ZO-1 levels as their wild-
type siblings. ZO-1 expression and localization in other tissues
were also similar in mutant and control animals (Supplementary
Fig. 8D). Accordingly, the jam3b mutation does not appear to
affect cardiomyocyte morphology (Supplementary Fig. 8E), as
assessed by measuring cardiomyocyte volume and surface area
(Supplementary Fig. 8F, G). Thus, our data confirm the suitability
of the jam3b mutant as a fusion-deficient model.
At 48–52 hpf, while Tg(ubb:FATC)bns97;Tg(hsp:cre);jam3b+/?
(wild-type or heterozygous for jam3b) embryos exhibited
exclusively multinucleated fast twitch muscles, the majority of
myocytes in jam3b−/− embryos were mononucleated (Fig. 7a;
Supplementary Fig. 9A−P), indicating cell fusion defects.
Correspondingly, Jam3b deficiency caused a 78% reduction in
the number of LIFEACT-GFP+ skeletal myocytes in 48–52 hpf
embryos after heat-induction at 24 hpf to drive ubiquitous cre
expression (Fig. 7a, c; Supplementary Fig. 9A–P). Importantly,
LIFEACT-GFP expression could only be observed in the few
multinucleated myocytes, providing additional verification for the
suitability of the tool to report cell fusion (Supplementary
Fig. 9Q). We observed a similar decrease (77%) in the number of
LIFEACT-GFP+ cardiomyocytes in jam3b mutants (Fig. 7b, d),
further supporting the occurrence of cell/membrane fusion in the
myocardium. Analysis after a 16 h EdU pulse showed that the
percentage of ventricular cardiomyocytes undergoing DNA
synthesis in 6 dpf jam3b−/− larvae was ~33% lower than in
wild-type siblings (Fig. 7e, f). Accordingly, 6 dpf mutant ventricles
contained, on average, 16% less cardiomyocytes than wild-type
siblings (Fig. 7g). Moreover, most jam3b−/− mutants exhibited
pericardial edema by 5 dpf (Fig. 7h). While heart rate was only
slightly affected (132± 2.4 versus 120± 3 beats per minute in
wild-type siblings and jam3b mutants, respectively, p= 0.01 t-
test), loss of Jam3b markedly decreased ventricular fractional
shortening (Fig. 7i) and blood flow velocity (Fig. 7j, k) when
analyzed at 5 dpf, indicating defective cardiac contractility.
Altogether, these findings suggest the requirement of membrane
fusion for cardiomyocyte proliferation and cardiac function.
Unaltered cardiomyocyte ploidy following membrane fusion.
Multi-nucleation, commonly observed in mammalian cardiomyo-
cytes and believed to be the result of abortive cytokinesis26 instead
of cell fusion, has been linked to lower cell cycle activity33, 34. In
contrast, we found evidence suggesting high mitotic activity of
cardiomyocytes after membrane fusion (Figs. 2c, 4d–h, and 6e, f).
Moreover, live imaging revealed transient fusion events that did
not lead to multi-nucleation (Fig. 2e; Supplementary Movie 1).
Further examination of proliferation events in fusion-derived car-
diomyocytes, detected in Tg(ubb:NATC)bns98;Tg(myl7:creER) larvae
treated with 4-OHT at 48–56 hpf and a subsequent EdU-pulse at
72–78 hpf, showed EdU incorporation in mononucleated cells
(Fig. 8a). To clarify whether the developing zebrafish heart contains
multinucleated cardiomyocytes, we analyzed Tg(myl7:GAL4);Tg
(UAS:EGFP-CAAX);Tg(myl7:nDsRed2) embryos at 54 hpf, a
developmental stage in which the myocardium is monolayered and
individual cardiomyocytes are identifiable by the presence of
membrane-localized EGFP-CAAX and nuclear nDsRed2. Exclud-
ing cell pairs showing partial membrane fusion, we observed
negligible numbers of binucleated cardiomyocytes (a total of 3
cardiomyocytes in 2 out of 10 embryos analyzed; a representative
image is shown in Fig. 8b). Consistent with our analysis, it has
been reported that the majority of cardiomyocytes in the adult
zebrafish heart are mononucleated35. To test the possible
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occurrence of nuclear fusion, which would lead to mononuclear
polyploid cells, we assessed the nuclear DNA content of cardio-
myocytes in Tg(ubb:NATC);Tg(myl7:creER) larvae at 7 dpf. Fused
cells were identified by NTR-mCherry expression following 4-
OHT treatment from 24 to 40 hpf. Intensity of DAPI staining was
used to quantify DNA amounts. Cells undergoing DNA synthesis,
which would alter DNA content, were labeled by a 16 h EdU
treatment. Fluorescence image analysis showed no difference in
the nuclear DNA content of NATC+ and NATC− cardiomyo-
cytes, suggesting that ploidy number was unchanged in cardio-
myocytes after membrane fusion (Fig. 8c). These data argue
against cell fusion leading to multinucleated or polyploid cardi-
omyocytes, and further suggest the presence of transient mem-
brane fusion events in the zebrafish heart.
Discussion
We describe here novel tools, Tg(ubb:FATC)bns97 and Tg(ubb:
NATC)bns98, that enable in vivo labeling and ablation of fusion-
derived cells. In addition to membrane or cell fusion, LIFEACT-
GFP expression observed in some skin cells (Supplementary
Fig. 1A), which have been reported to become polyploid through
endoreplication23, 24, suggests that endoreplication might also be
able to activate the FATC and NATC reporters. Use of these tools
led us to identify the myocardium, a tissue previously unknown
to undergo frequent membrane fusion.
Cell fusion is a well-known cellular event that involves com-
plete regression of the intercellular membranes to generate mul-
tinucleated, or mononucleated polyploid, cells. In contrast, we
found several lines of evidence that suggest an uncommon form
of fusion that does not give rise to multinucleated/polyploid
cardiomyocytes. Taking into account (1) the rarity of binucleated
cardiomyocytes (Fig. 8b), especially compared to the high num-
bers of mostly mononucleated (Fig. 5a, c, d), FATC+ (Fig. 5a, c)
and NATC+ (Fig. 5d, e) cardiomyocytes, (2) the transient nature
of membrane fusion events that do not give rise to stable binu-
cleated cells as documented by time-lapse imaging (Supplemen-
tary Movie 1; Fig. 2e), and (3) the unaltered ploidy of
cardiomyocytes after membrane fusion as assessed by DNA
content analysis (Fig. 8c), we conclude that transient membrane
fusion events that allow cytoplasmic connections is the most
likely mechanism by which cardiomyocytes activate the F/NATC
reporter.
Heterokaryon formation between transplanted endothelial/
hematopoietic lineage cells13, 14 or skeletal muscle-derived cells36
and host cardiomyocytes has been reported previously. Hema-
topoietic stem/progenitor cells, in particular, are able to fuse
homotypically37 and heterotypically8 with diverse cell types.
However, constitutive cre expression under control of the kdrl
promoter, which is active in endothelial and hematopoietic stem
cells38, did not induce LIFEACT-GFP expression in cardiomyo-
cytes (Supplementary Fig. 10). Instead, time-lapse imaging
showed membrane fusion between cardiomyocytes (Fig. 2e;
Supplementary Movie 1), indicating homotypic fusion.
Establishment of nanotubular structures that allow transient
exchange of cytoplasmic macromolecules and organelles between
cardiomyocytes and other cell types including mesenchymal stem
cells, endothelial progenitor cells, and fibroblasts has been
observed in vitro39, 40 and in vivo19, indicating functional sig-
nificance of partial membrane fusion. Accordingly, our work has
uncovered a correlation between membrane fusion and mitotic
activity of cardiomyocytes in response to the proliferative demand
during development (Fig. 5d–h) and regeneration (Fig. 6d–f). It
will be interesting to clarify the nature of this relationship and its
underlying mechanism. While supporting data are needed, two
possible scenarios might occur upon membrane fusion. One
scenario is the presence of a proliferation competent cardio-
myocyte population for which membrane fusion and exchange of
cytoplasmic materials drives their entry into the cell cycle.
Another scenario involves a fusion-triggered metabolic switch to
aerobic glycolysis, which has long been considered a requirement
for cell proliferation41. This speculation is in line with an earlier
posited hypothesis that fusion between cancer cells and leuko-
cytes can generate hybrid cells that use aerobic glycolysis to fuel
their transition to malignancy42.
We describe here cardiac defects in jam3b mutants. The
reduction in jam3b mutants of FATC reporter expression
(Fig. 7a–d), of cardiomyocyte S-phase indexes, of total cardio-
myocyte numbers, coupled with defective cardiac contractility
(Fig. 7e–k), but without obvious changes in cardiomyocyte
adhesion or morphology (Supplementary Fig. 8) suggests a
requirement for Jam3b-mediated cardiomyocyte fusion in cardiac
development and function. It has been postulated that fusion
serves an essential function in skeletal myogenesis by allowing the
generation of continuous sarcomeric arrays important for con-
tractility1. Sarcomere alignment between adjacent cardiomyocytes
to enhance synchronous contractions43 might be facilitated by
cardiomyocyte fusion, even though the transient fusion events do
not generate long-lasting multinuclear syncytia. Alternatively, the
reduction in the number of ventricular cardiomyocytes in jam3b
mutants (Fig. 7e–g) could directly contribute to cardiac dys-
function, and further analysis will determine whether these or
additional mechanisms are at play in mediating the develop-
mental and functional roles of Jam3b in the heart. The human
homolog of jam3b, JAM-3, was identified as a candidate gene
within a chromosomal region associated with congenital heart
defects in Jacobsen Syndrome44. Mice lacking JAM-C, a jam3b
ortholog, exhibit no gross cardiac abnormalities44 but die peri-
natally from respiratory distress45. The phenotypes we observed
in the zebrafish jam3b mutant hearts lead us to speculate that
cardiomyocyte fusion is an indispensable process in vertebrates.
Furthermore, the correlation between cardiomyocyte fusion and
mitotic activity calls for additional studies of the underlying
mechanisms of cell fusion, which may lead to a better under-
standing of the distinct regenerative capacity of the zebrafish
heart and provide new avenues for repairing the damaged
mammalian heart.
Methods
Fish care and strains. All zebrafish husbandry was performed under standard
conditions in accordance with institutional (MPG) and national German ethical
and animal welfare guidelines. Transgenic lines used in this study include: Tg(ubb:
lox2272-mCerulean-UAS-loxP-lox2272-GAL4-loxP-LIFEACT-GFP)bns97, Tg(ubb:
lox2272-mCerulean-UAS-loxP-lox2272-GAL4-loxP-NTR-mCherry)bns98, Tg(hsp70l:
cre)zdf13, 46, Tg(myl7:Cre-ERT2)pd12, 11, Tg(myl7:DsRed2-NLS)f2, 47, Tg(myl7:
MKATE-CAAX)sd11, 48, Tg(myl7:EGFP)twu26, 49, Tg(myl7:H2B-GFP)zf52, 50, Tg(kdrl:
Cre)s898, 51, Tg(myl7:GAL4), Tg(UAS:EGFP-CAAX)m1230, 52, and Tg(actb2:loxP-
DsRed-loxP-EGFP)s928, 11.
Generation of transgenic animals. To generate the ubb:lox2272-mCerulean-
UAS-loxP-lox2272-GAL4-loxP-LIFEACT-GFP construct, the ubb promoter from
Tg(ubb:loxP-EGFP-loxP-mCherry)cz1701, 53, lox2272-mCerulean from CMV-
Brainbow-1.1 M, loxP-5XUAS-E1b, rabbit β-globin intron from pT2KXIGΔin ref.
54, lox2272-GAL4TA4-loxP, and LIFEACT-GFP from Tg(myl7:LIFEACT-GFP)
s974, 55 were amplified by polymerase chain reaction (PCR) and cloned into a
miniTol2 vector. The ubb:lox2272-mCerulean-UAS-loxP-lox2272-GAL4-loxP-
NTR-mCherry construct was generated by replacing LIFEACT-GFP in the ubb:
lox2272-mCerulean-UAS-loxP-lox2272-GAL4-loxP-LIFEACT-GFP plasmid with
NTR-mCherry, PCR-amplified from Tg(UAS-E1b:NTR-mCherry)i149, 56.
Injected fish were selected for mCerulean expression and raised to adulthood.
Identified founders were outcrossed and subsequent generations were raised and
expanded. Most of the animals used in this study were F4 animals obtained from
consecutive outcrosses.
Heat shock and tamoxifen treatment. For heat induction of cre expression,
embryos or adults were transferred into fresh Danieau buffer or system water
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preheated to 38–39 ºC and kept at this temperature for 1 h. Activation of Cre-ERT2
in embryos was done by addition of ethanol-stocked 4-hydroxytamoxifen (4-OHT,
Sigma) in Danieau buffer to a final concentration of 5 μM. For adults, 0.01 mg of 4-
OHT (~0.05 mg/g of body weight) was delivered by intraperitoneal injections.
EdU treatment and immunofluorescent staining. To assess mitotic activity, EdU
(Thermo Fisher) was diluted in Danieau buffer containing phenylthiourea (PTU)
to a concentration of 5 mM. Embryos/larvae were immersed in EdU medium,
containing 1.5% DMSO to enhance permeability, and incubated at 28 ºC for the
indicated times before fixation. Adult fish were injected with 0.04 mg of EdU
intraperitoneally (~0.2 mg/g of body weight).
For EdU and immunofluorescence staining, samples were fixed with 4%
paraformaldehyde (PFA) at 4 °C overnight, washed with PBS buffer containing
0.1% (V/V) Tween 20 (PBST), and incubated with 1 mg/ml collagenase (Sigma) in
PBST at 37 °C for 1.5 h to improve antibody penetration. Before proceeding to
staining, the pericardium was removed from embryos/larvae and adult hearts were
treated with 10 μg/ml proteinase K in PBST for 30 min at room temperature (RT).
EdU staining was performed according to the Click-iT protocol provided by the
manufacturer (Thermo Fisher Scientific). Next, samples were incubated at RT for 2
h in blocking buffer (PBS supplemented with 0.3% (V/V) Triton X-100 and 1%
DMSO (PBSTD) and contained 2% (W/V) BSA and 4% (V/V) goat serum),
followed by primary antibodies diluted in blocking buffer for 48–72 h at 4 °C. After
washing out unbound primary antibodies with PBSTD, samples were incubated
with Alexa Fluor-conjugated secondary antibodies (Thermo Fisher Scientific) in
blocking solution (dilution 1:500) for 2 h at RT, washed with PBSTD and mounted
in Fluoromount aqueous mounting medium (Sigma) for imaging. Antibodies and
dilutions are: 1:300 rabbit anti-phospho-Histone H3 (Millipore), 1:50 mouse anti-
phospho-histone H3 (C-2, Santa Cruz), 1:500 rabbit anti-RFP (MBL), 1:500 chick
anti-GFP (Molecular Probes), and 1:50 mouse anti-ZO-1 (Thermo Fisher
Scientific). The monoclonal mouse anti-F59 and anti-EB165 antibodies were
obtained from the Developmental Studies Hybridoma Bank, created by NICHD of
the NIH and maintained at the University of Iowa, Iowa, USA.
To quantify numbers of NATC+ and proliferating cardiomyocytes, all single-
plane images from confocal stacks that covered the entire cardiac ventricle were
analyzed. Cells showing NTR-mCherry expression or EdU-labeled nuclei that were
entirely embedded within NTR-mCherry+ cytoplasm were scored in ImageJ. Total
cardiomyocyte numbers were quantitated using Imaris software.
Time-lapse microscopy. Embryos were embedded in 1.5% low-melting agarose in
glass-bottom dishes (MatTek). The dishes were then filled with Danieau buffer
containing 0.016% Tricaine to anesthetize the embryos. Confocal Z-stacks were
acquired from the heart every 20–30 min for 17 h using a ×40 water immersion
objective. Maximum intensity projections of each time frame were rendered into
time-lapse movies with Fiji software.
Morpholino injections and blastula transplantations. For time-lapse imaging, 5
ng of tnnt2 morpholino30 and 20–40 pg of cre or creER mRNA was injected in
embryos at 1–4-cell stage. For transplantation, embryos were dechorionated by
treatment with 1 mg/ml pronase (Sigma) in Danieau buffer and maintained on
agarose-coated Petri dishes until 1k-cell stage. Embryos were then transferred into
agar mold that contained rows of wells large enough to hold 1–2 embryos. In
Ringer’s buffer containing Penicillin/Streptomycin, donor cells were transplanted
into host embryos along the blastoderm margin. Transplantations were continued
until embryos developed to the 30%-epiboly stage. Transplanted embryos were
raised to 24 hpf in Ringer’s buffer containing Penicillin/Streptomycin on agarose-
coated petri dishes and transferred into uncoated dishes with Danieau buffer for
further development.
Cardiac injury. Fish were anesthetized with tricaine and placed on a soft sponge
soaked in system water containing tricaine with their ventral side exposed. After
removing scales from the chest area, a small longitudinal incision was made from
the operculum to the pectoral fin level. A liquid nitrogen-cooled stainless steel
probe was placed on the ventricle for 20–30 s to induce cryoinjury. Injured fish
were left in small tanks containing system water to recover from anesthesia before
returning them back to water-flowing tanks.
Cardiac contractility measurements. Five days post fertilization, larvae obtained
from jamb+/− incrosses were embedded in 2% low-melting point agarose. PTU was
applied to the animals starting from 1 dpf to block skin pigmentation. The heart
ventricle and a segment of the dorsal aorta were imaged with a transmitted light
microscope equipped with a ×20 objective (Olympus) and a high-speed camera
(Andor). Four seconds long movies were acquired at 420 frames per second.
To calculate ventricular fractional shortening, the width of the ventricle at the
maximum ventricular diastole (widthVD) and ventricular systole (widthVS) were
measured in Fiji. The ventricular fractional shortening was calculated as
[(widthVD – widthVS)/widthVD].
Blood velocity was calculated in two steps. First, kymograms (space-time images
representing the motion of particles as oblique lines) of blood cell movement in the
dorsal aorta were generated with Fiji using the Velocity Measurement Tool (http://
dev.mri.cnrs.fr/projects/imagej-macros/wiki/Velocity_Measurement_Tool).
Second, the kymograms were filtered with a temporal demeaning algorithm, and
blood flow velocity was calculated from the angles of the lines in the kymograms
using a Matlab code57.
Quantification of DNA content. Twenty-four hours post fertilization, Tg(ubb:
NATC);Tg(myl7:creER) embryos were treated with 4-OHT for 16 h. After a 16 h
pulse of EdU at 6 dpf, NTR-mCherry+ and EdU+ cells were detected by immu-
nofluorescence staining. DNA was stained with DAPI (1 μg/ml for 2 h at RT).
Nuclear DAPI intensities of cardiac cells were quantified from 3D volumes
obtained from confocal images using ImarisCell software.
Data availability. All data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding
authors upon reasonable request.
Received: 26 November 2016 Accepted: 27 September 2017
References
1. Abmayr, S. M. & Pavlath, G. K. Myoblast fusion: lessons from flies and mice.
Development 139, 641–656 (2012).
2. Helming, L. & Gordon, S. Molecular mediators of macrophage fusion. Trends
Cell. Biol. 19, 514–522 (2009).
3. Pawelek, J. M. & Chakraborty, A. K. Fusion of tumour cells with bone marrow-
derived cells: a unifying explanation for metastasis. Nat. Rev. Cancer 8, 377–386
(2008).
4. Blau, H. et al. Plasticity of the differentiated state. Science 230, 758–766 (1985).
5. Cowan, C. A. Nuclear reprogramming of somatic cells after fusion with human
embryonic stem cells. Science 309, 1369–1373 (2005).
6. Brady, J. J. et al. Early role for IL-6 signalling during generation of induced
pluripotent stem cells revealed by heterokaryon RNA-Seq. Nat. Cell. Biol. 15,
1244–1252 (2013).
7. Vassilopoulos, G., Wang, P.-R. & Russell, D. W. Transplanted bone marrow
regenerates liver by cell fusion. Nature 422, 901–904 (2003).
8. Wang, X. et al. Cell fusion is the principal source of bone-marrow-derived
hepatocytes. Nature 422, 897–901 (2003).
9. Shenje, L. T. et al. Mutations in Alström protein impair terminal differentiation
of cardiomyocytes. Nat. Commun. 5, https://doi.org/10.1038/ncomms4416
(2014).
10. Jopling, C. et al. Zebrafish heart regeneration occurs by cardiomyocyte
dedifferentiation and proliferation. Nature. 464, 606–609 (2010).
11. Kikuchi, K. et al. Primary contribution to zebrafish heart regeneration by gata4
cardiomyocytes. Nature. 464, 601–605 (2010).
12. Berlo, J. H. V. et al. c-kit cells minimally contribute cardiomyocytes to the heart.
Nature 509, 337–341 (2014).
13. Alvarez-Dolado, M. et al. Fusion of bone-marrow-derived cells with Purkinje
neurons, cardiomyocytes and hepatocytes. Nature 425, 968–973 (2003).
14. Nygren, J. M. et al. Bone marrow–derived hematopoietic cells generate
cardiomyocytes at a low frequency through cell fusion, but not
transdifferentiation. Nat. Med. 10, 494–501 (2004).
15. Oh, H. et al. Cardiac progenitor cells from adult myocardium: homing,
differentiation, and fusion after infarction. Proc. Natl Acad. Sci. 100,
12313–12318 (2003).
16. Song, Y.-H., Pinkernell, K. & Alt, E. Stem cell induced cardiac regeneration:
fusion/mitochondrial exchange and/or transdifferentiation? Cell Cycle 10,
2281–2286 (2011).
17. Aguilar, P. S. et al. Genetic basis of cell–cell fusion mechanisms. Trends Genet.
29, 427–437 (2013).
18. Santos-Ferreira, T. et al. Retinal transplantation of photoreceptors results in
donor–host cytoplasmic exchange. Nat. Commun. 7, https://doi.org/10.1038/
ncomms13028 (2016).
19. Driesen, R. et al. Partial cell fusion: a newly recognized type of communication
between dedifferentiating cardiomyocytes and fibroblasts. Cardiovasc. Res. 68,
37–46 (2005).
20. Siegel, R. W., Jain, R. & Bradbury, A. Using an in vivo phagemid system to
identify non-compatible loxP sequences. FEBS Lett. 505, 467–473 (2001).
21. Chatterjee, P. K. Mutually exclusive recombination of wild-type and
mutant loxP sites in vivo facilitates transposon-mediated deletions from
both ends of genomic DNA in PACs. Nucleic Acids Res. 32, 5668–5676
(2004).
22. Jackson, H. E. & Ingham, P. W. Control of muscle fibre-type diversity during
embryonic development: the zebrafish paradigm. Mech. Dev. 130, 447–457
(2013).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01555-8
14 NATURE COMMUNICATIONS |8:  1525 |DOI: 10.1038/s41467-017-01555-8 |www.nature.com/naturecommunications
23. Zanet, J. et al. Endogenous Myc controls mammalian epidermal cell size,
hyperproliferation, endoreplication and stem cell amplification. J. Cell. Sci. 118,
1693–1704 (2005).
24. Zanet, J. et al. A mitosis block links active cell cycle with human epidermal
differentiation and results in endoreplication. PLoS ONE 5, https://doi.org/
10.1371/journal.pone.0015701 (2010).
25. Riedl, J. et al. Lifeact: a versatile marker to visualize F-actin. Nat. Methods 5,
605–607 (2008).
26. Engel, F. B., Schebesta, M. & Keating, M. T. Anillin localization defect in
cardiomyocyte binucleation. J. Mol. Cell. Cardiol. 41, 601–612 (2006).
27. Walsh, S., Pontén, A., Fleischmann, B. K. & Jovinge, S. Cardiomyocyte cell cycle
control and growth estimation in vivo—an analysis based on cardiomyocyte
nuclei. Cardiovasc. Res. 86, 365–373 (2010).
28. Curado, S. et al. Conditional targeted cell ablation in zebrafish: A new tool for
regeneration studies. Dev. Dyn. 236, 1025–1035 (2007).
29. Pisharath, H., Rhee, J. M., Swanson, M. A., Leach, S. D. & Parsons, M. J.
Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli
nitroreductase. Mech. Dev. 124, 218–229 (2007).
30. Sehnert, A. J. et al. Cardiac troponin T is essential in sarcomere assembly and
cardiac contractility. Nat. Genet. 31, 106–110 (2002).
31. Powell, G. T. & Wright, G. J. Jamb and jamc are essential for vertebrate
myocyte fusion. PLoS Biol. 9, https://doi.org/10.1371/journal.pbio.1001216
(2011).
32. Ebnet, K. The junctional adhesion molecule (JAM) family members JAM-2 and
JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs
in endothelial cell polarity. J. Cell. Sci. 116, 3879–3891 (2003).
33. Bersell, K., Arab, S., Haring, B. & Kühn, B. Neuregulin1/ErbB4 signaling
induces cardiomyocyte proliferation and repair of heart injury. Cell 138,
257–270 (2009).
34. Senyo, S. E., Lee, R. T. & Kühn, B. Cardiac regeneration based on mechanisms
of cardiomyocyte proliferation and differentiation. Stem Cell Res. 13, 532–541
(2014).
35. Wills, A. A., Holdway, J. E., Major, R. J. & Poss, K. D. Regulated addition of
new myocardial and epicardial cells fosters homeostatic cardiac growth and
maintenance in adult zebrafish. Development 135, 183–192 (2007).
36. Matsuura, K. et al. Cardiomyocytes fuse with surrounding noncardiomyocytes
and reenter the cell cycle. J. Cell. Biol. 167, 351–363 (2004).
37. Skinner, A. M., Grompe, M. & Kurre, P. Intra-hematopoietic cell fusion as a
source of somatic variation in the hematopoietic system. J. Cell. Sci. 125,
2837–2843 (2012).
38. Sawamiphak, S., Kontarakis, Z. & Stainier, D. Y. Interferon gamma signaling
positively regulates hematopoietic stem cell emergence. Dev. Cell. 31, 640–653
(2014).
39. Koyanagi, M. Cell-to-cell connection of endothelial progenitor cells with
cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ.
Res. 96, 1039–1041 (2005).
40. Acquistapace, A. et al. Human mesenchymal stem cells reprogram adult
cardiomyocytes toward a progenitor-like state through partial cell fusion and
mitochondria transfer. Stem Cells 29, 812–824 (2011).
41. Heiden, M. G. V., Cantley, L. C. & Thompson, C. B. Understanding the
warburg effect: the metabolic requirements of cell proliferation. Science 324,
1029–1033 (2009).
42. Lazova, R., Chakraborty, A. & Pawelek, J. M. Leukocyte-cancer cell fusion:
initiator of the warburg effect in malignancy? Adv. Exp. Med. Biol. 714,
151–172 (2011).
43. Benz, P. M. et al. Mena/VASP and αII-Spectrin complexes regulate cytoplasmic
actin networks in cargdiomyocytes and protect from conduction abnormalities
and dilated cardiomyopathy. Cell Commun. Signal. 11, 56, https://doi.org/
10.1186/1478-811X-11-56 (2013).
44. Ye, M. et al. Deletion of JAM-C, a candidate gene for heart defects in Jacobsen
syndrome, results in a normal cardiac phenotype in mice. Am. J. Med. Genet. A
149A, 1438–1443 (2009).
45. Praetor, A. et al. Genetic deletion of JAM-C reveals a role in myeloid progenitor
generation. Blood 113, 1919–1928 (2008).
46. Feng, H. et al. Heat-shock induction of T-cell lymphoma/leukaemia in
conditional Cre/lox-regulated transgenic zebrafish. Br. J. Haematol. 138,
169–175 (2007).
47. Rottbauer, W. et al. Reptin and pontin antagonistically regulate heart growth in
zebrafish embryos. Cell 111, 661–672 (2002).
48. Lin, Y.-F., Swinburne, I. & Yelon, D. Multiple influences of blood flow on
cardiomyocyte hypertrophy in the embryonic zebrafish heart. Dev. Biol. 362,
242–253 (2012).
49. Huang, C.-J., Tu, C.-T., Hsiao, C.-D., Hsieh, F.-J. & Tsai, H.-J. Germ-line
transmission of a myocardium-specific GFP transgene reveals critical
regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish.
Dev. Dyn. 228, 30–40 (2003).
50. Mickoleit, M. et al. High-resolution reconstruction of the beating zebrafish
heart. Nat. Methods 11, 919–922 (2014).
51. Bertrand, J. Y. et al. Haematopoietic stem cells derive directly from aortic
endothelium during development. Nature 464, 108–111 (2010).
52. Fernandes, A. M. et al. Deep brain photoreceptors control light-seeking
behavior in zebrafish larvae. Curr. Biol. 22, 2042–2047 (2012).
53. Mosimann, C. et al. Ubiquitous transgene expression and Cre-based
recombination driven by the ubiquitin promoter in zebrafish. Development 138,
169–177 (2010).
54. Urasaki, A., Morvan, G. & Kawakami, K. Functional dissection of the Tol2
transposable element identified the minimal cis-sequence and a highly
repetitive sequence in the subterminal region essential for transposition.
Genetics. 174, 639–649 (2006).
55. Reischauer, S., Arnaout, R., Ramadass, R. & Stainier, D. Y. R. Actin binding
GFP allows 4D in vivo imaging of myofilament dynamics in the zebrafish heart
and the identification of Erbb2 signaling as a remodeling factor of myofibril
architecture. Circ. Res. 115, 845–856 (2014).
56. Gray, C. et al. Simultaneous intravital imaging of macrophage and neutrophil
behaviour during inflammation using a novel transgenic zebrafish. Thromb.
Haemost. 105, 811–819 (2011).
57. Chhatbar, P. Y. & Kara, P. Improved blood velocity measurements with a
hybrid image filtering and iterative Radon transform algorithm. Front.
Neurosci. 7, https://doi.org/10.3389/fnins.2013.00106 (2013).
Acknowledgements
We thank Herwig Baier for providing experimental reagents, Dan Hesselson for helpful
discussions on the FATC construct design, Markella Katidou for assistance with
Southern blotting, and Darius Balciunas and Chi-Chung Wu for comments on the
manuscript. S.S. and A.F. would also like to acknowledge technical support from the staff
of the Advanced Light Microscopy Technology Platform at the Max Delbrück Center for
Molecular Medicine. This work was supported by the Human Frontier Science
Program (LT 001167/2011-L) to S.S., the EMBO (ALTF 1229-2012) to Z.K., the
Deutsche Forschungsgemeinschaft (German Research Foundation; RE 3148/1-1 and SFB
1213-B01) to S.R., and funding from the NIH (HL54737) and the Max Planck Society to
D.Y.R.S.
Author contributions
S.S. designed the project, performed most experiments, analyzed and interpreted data,
and wrote the manuscript. Z.K. designed experiments, carried out transgene copy
number assessment and cardiac injury, and edited and critically reviewed the manuscript.
A.F. designed experiments, performed cardiac function assessment, analyzed ZO-1
expression and nuclear DNA content, and critically reviewed the manuscript. S.R. con-
ceived and designed the FATC system, and critically reviewed the manuscript. D.Y.R.S.
provided critical scientific inputs throughout the project as well as funding, supervision
and mentoring, and edited the manuscript.
Additional information
Supplementary Information accompanies this paper at doi:10.1038/s41467-017-01555-8.
Competing interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2017
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01555-8 ARTICLE
NATURE COMMUNICATIONS |8:  1525 |DOI: 10.1038/s41467-017-01555-8 |www.nature.com/naturecommunications 15
